Literature DB >> 23154432

TLR7 contributes to the rapid progression but not to the overall fatal outcome of secondary pneumococcal disease following influenza A virus infection.

Sabine Stegemann-Koniszewski1, Marcus Gereke, Sofia Orrskog, Stefan Lienenklaus, Bastian Pasche, Sophie R Bader, Achim D Gruber, Shizuo Akira, Siegfried Weiss, Birgitta Henriques-Normark, Dunja Bruder, Matthias Gunzer.   

Abstract

Increased risk for bacterial superinfections substantially contributes to the mortality caused by influenza A virus (IAV) epidemics. While the mechanistic basis for this lethal synergism is still insufficiently understood, immune modulation through the viral infection has been shown to be involved. Since the pattern-recognition receptor (PRR) toll-like receptor 7 (TLR7) is a major sensor for the viral genome, we studied how IAV recognition by TLR7 influences the development of secondary pneumococcal infection. In a mouse model of IAV, TLR7-deficient hosts induced a potent antiviral response and showed unchanged survival. In secondary pneumococcal infection during acute influenza, TLR7ko mice showed a fatal outcome similar to wild-type (WT) hosts, despite significantly delayed disease progression. Also, when bacterial superinfection occurred after virus clearance, WT and TLR7-deficient hosts showed similar mortality, even though we found the phagocytic activity of alveolar macrophages isolated from IAV-pre-infected hosts to be enhanced in TLR7ko over WT mice. Thus, we show that a virus-sensing PRR modulates the progression of secondary pneumococcal infection following IAV. However, the fatal overall outcome in WT as well as TLR7ko hosts suggests that processes distinct from TLR7-triggering override the contribution of this single PRR.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23154432      PMCID: PMC6741512          DOI: 10.1159/000345112

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  13 in total

1.  TLR7 Expression Aggravates Invasive Pulmonary Aspergillosis by Suppressing Anti-Aspergillus Immunity of Macrophages.

Authors:  Banglao Xu; Qin Luo; Yi Gong; Jiaxi Li; Ju Cao
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

2.  Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding.

Authors:  Mihai Nita-Lazar; Aditi Banerjee; Chiguang Feng; Mohammed N Amin; Matthew B Frieman; Wilbur H Chen; Alan S Cross; Lai-Xi Wang; Gerardo R Vasta
Journal:  Mol Immunol       Date:  2015-01-16       Impact factor: 4.407

3.  Propofol directly binds to and inhibits TLR7.

Authors:  Sophia Koutsogiannaki; Weiming Bu; Wiriya Maisat; Mariel Manzor; Zhikuan Zhang; Umeharu Ohto; Roderic G Eckenhoff; Koichi Yuki
Journal:  FASEB J       Date:  2022-08       Impact factor: 5.834

Review 4.  Modeling Influenza Virus Infection: A Roadmap for Influenza Research.

Authors:  Alessandro Boianelli; Van Kinh Nguyen; Thomas Ebensen; Kai Schulze; Esther Wilk; Niharika Sharma; Sabine Stegemann-Koniszewski; Dunja Bruder; Franklin R Toapanta; Carlos A Guzmán; Michael Meyer-Hermann; Esteban A Hernandez-Vargas
Journal:  Viruses       Date:  2015-10-12       Impact factor: 5.048

5.  Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance.

Authors:  Julia D Boehme; Sabine Stegemann-Koniszewski; Andrea Autengruber; Nicole Peters; Josef Wissing; Lothar Jänsch; Andreas Jeron; Dunja Bruder
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

6.  Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation via Toll-Like Receptor 7.

Authors:  Sabine Stegemann-Koniszewski; Sarah Behrens; Julia D Boehme; Inga Hochnadel; Peggy Riese; Carlos A Guzmán; Andrea Kröger; Jens Schreiber; Matthias Gunzer; Dunja Bruder
Journal:  Front Immunol       Date:  2018-02-13       Impact factor: 7.561

7.  RIG-I Signaling via MAVS Is Dispensable for Survival in Lethal Influenza Infection In Vivo.

Authors:  Wenxin Wu; Xiaoqiu Wang; Wei Zhang; Lili Tian; J Leland Booth; Elizabeth S Duggan; Sunil More; Lin Liu; Mikhail Dozmorov; Jordan P Metcalf
Journal:  Mediators Inflamm       Date:  2018-11-08       Impact factor: 4.711

8.  In vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infection.

Authors:  Niharika Sharma-Chawla; Sabine Stegemann-Koniszewski; Henrike Christen; Julia D Boehme; Olivia Kershaw; Jens Schreiber; Carlos A Guzmán; Dunja Bruder; Esteban A Hernandez-Vargas
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

9.  Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice.

Authors:  T Kramskaya; G Leontieva; Yu Desheva; K Grabovskaya; T Gupalova; L Rudenko; A Suvorov
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

10.  Alveolar Type II Epithelial Cells Contribute to the Anti-Influenza A Virus Response in the Lung by Integrating Pathogen- and Microenvironment-Derived Signals.

Authors:  S Stegemann-Koniszewski; Andreas Jeron; Marcus Gereke; Robert Geffers; Andrea Kröger; Matthias Gunzer; Dunja Bruder
Journal:  MBio       Date:  2016-05-03       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.